Jeff Reeves

Jeff Reeves

Jeff Reeves is a financial commentator with almost two decades of newsroom and markets experience, including a stint as an editor for the New York Times Co. He has been lead writer and editor for InvestorPlace.com since the beginning of 2010.  

Jeff’s work has appeared in numerous finance publications and broadcast outlets, including The Wall Street Journal network, CNBC, TheStreet.com, Fox Business Channel, USA Today and a host of others.

View some of his TV appearances on YouTube, or check out his writing links below.

Jeff has also penned an eBook, The Frugal Investor’s Guide to Finding Great Stocks: 11 Free Resources to Help Beginners Identify Fantastic Investments.

Write Jeff at editor@investorplace.com, or follow him on Twitter @JeffReevesIP.

Recent Articles

Yahoo Earnings Flop – What Does it Mean for Alibaba IPO?

By Jeff Reeves

Yahoo earnings stunk, and YHOO stock is fading on poor ad numbers. But the Alibaba IPO remains the big draw. So what's next for Yahoo stock?

Google Earnings – Is GOOG Stock a Buy?

By Jeff Reeves

Despite weaker Q1 earnings, Google stock has fought back to near all-time highs. So should you buy Google at these levels, or pass?

AAPL – Will Apple Stock Keep Soaring Past All-Time Highs?

By Jeff Reeves

Apple stock is about to set a new all time high. But investors shouldn't expect AAPL to push much higher than that in the months ahead.

Generic Drug Stocks Soar – Your Best Healthcare Plays Are TEVA and MYL

By Jeff Reeves

Mylan just announced a deal to buy Abbott Labs' global generics business. MYL stock is popping now, but should run for some time thanks to the big tailwind that generic drug stocks are getting right now.

WARNING: A 10% Correction is Coming

By Jeff Reeves

Trouble at home and abroad means a correction could be looming. Now's the time to consider portfolio protection and even selling some positions.

Load More